Posted by AGORACOM-JC
at 8:53 AM on Thursday, September 30th, 2021
Earlier today Novamind Inc. (NM : CSE) (NVMDF: OTCQB) (HN2: FSE) opened its sixth integrative psychiatry clinic. The “Murray Clinic” also serves as Novamind’s third clinical research site, further strengthening the Company’s capabilities for serving drug developers via multiple sites and access to a large patient population.
The Company anticipates 65,000 visits to its clinics this year.
Yaron Conforti, CEO and Director, “Bringing cost-effective and innovative psychedelic therapies to market requires a large base of diverse candidates and the expertise to safely and effectively run complex clinical trials in the right environment. We continue to build on our model’s proven track record through the expansion of our clinics and research sites, and we expect to scale this unique operating model into additional states in the near term.”
Sit back, relax and watch this powerful interview with Yaron Conforti, CEO and Director of Novamind.
Posted by AGORACOM-JC
at 5:46 PM on Wednesday, September 29th, 2021
“I was blown away by FOBI “ ($KO CEO Daniel Petrov)
“Kiaro has built an amazing tech driven cannabis retail business” ($FOBI CEO Rob Anson)
If you’re a shareholder of one of these companies, here is what you need to know about each that makes this technology partnership so powerful:
KIARO is one of Canada’s largest retailers of cannabis, with 16 locations and forecasted annual revenue of $42.7 million from these locations, at a gross profit of $13.7M with further growth anticipated.
FOBI is a global leader in providing real-time data analytics through artificial intelligence to drive customer activation and engagement in the brick and mortar space. From that core technology they have built a technology stack on top of it that is second to none.
More than just talk, FOBI has completes Integrations with Lightspeed and Shopify to provide real-time Point of Sale data analytics. Moreover, they recently announced another $250.000 Data Consulting Agreement with Azincourt Energy
Posted by AGORACOM-JC
at 4:03 PM on Wednesday, September 29th, 2021
CurrencyWorks (CWRK: CSE) (CWRK: OTCQB) builds digital currencies for brands, companies, and communities to empower the free exchange of value between customers and users.
On September 24, 2021, bidding began for the Platinum and Elite NFTs. The one-of-one ZERO CONTACT Platinum Edition NFT sold for $56,860.00 USD and the ZERO CONTACT Elite Edition NFTs sold for a total of $36,575.00 USD. Additionally, CurrencyWorks receives an ongoing royalty every time these NFTs are bought and sold.
What did Cameron Chell, Chairman of CurrencyWorks have to say?
“We are extremely proud of the ZERO CONTACT NFTs that CurrencyWorks created on VUELE. This is a significant advancement for film distribution and digital collectibles,” said Cameron Chell, co-head of VUELE and Executive Chairman of CurrencyWorks.
Sit back and watch this powerful interview with company chairman Cameron Chell.
Posted by AGORACOM-JC
at 9:33 AM on Wednesday, September 29th, 2021
When 99.8% of investors read the headline to this press release, you couldn’t blame them for not understanding what it meant or how important it is to the future of POET Technologies
POET Technologies Launches Its Products and Optical Interposer Platform in China to Critical Acclaim
But this is the great thing about AGORACOM Beyond The Press Release, which provides investors with a layman’s understanding the importance of headlines like this to the business of $PTK ….
Last week in China was an important one for $PTK. The Company participated in two leading optoelectronics conferences / exhibitions in China at which they introduced POET to the China market (where most of the customers are), and demonstrated their technology across a range of products.
HOW WELL DID THE PRESENTATIONS GO?
That can easily be summarized by this powerful quote:
““The companies that attended the live demos now know who POET is and the significant value that we can provide to them. We were already engaged with a few customers, such as Fibertop and their commitment to adopt POET optical engines in their optical modules is a breakthrough for us. Other companies requested samples of our demonstrated products, and several more want to either engage in development contracts that would incorporate POET Optical Engines in their products or have POET incorporate their components into POET’s Optical Engines. Numerous opportunities for increased customer engagement in China, including with some of the largest players,”
WHAT KIND OF COMPANIES DID POET MEET AND DEMO THEIR PRODUCTS TO IN CHINA
More than 60 C-level and senior R&D executives representing over 20 companies, including:
Major China-based network equipment suppliers
Tier 1 transceiver module companies
Leading optical module and fiber optic companies (several of which are publicly traded)
Data center operators … and
Major multi-billion-dollar public enterprise companies seeking to expand into the optical transceiver business
You don’t have to be a computer scientist to understand the potential of these target markets. But you do have to watch this powerful interview in its entirety to understand the big picture.
In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison are joined by Dr. Paul Thielking. Paul is a psychiatrist, zen practitioner, and Chief Scientific Officer at Novamind. They discuss healthcare provider burnout and other unique challenges of being in the helping/healing professions.
We are pleased to announce that we have been included in the AdvisorShares Psychedelics ETF trading on the NYSE under the ticker “PSIL” (the “ETF”).
PSIL is the first U.S.-listed, actively managed exchange traded fund to deliver dedicated investment exposure to psychedelics. PSIL seeks long-term capital appreciation by investing in the rapidly evolving psychedelics space, offering exposure to companies which the ETF’s portfolio manager views as leading the way in this nascent industry. The ETF currently includes 22 psychedelics companies.
“The inclusion of Novamind in the AdvisorShares Psychedelics ETF is an important achievement for our Company,” commented Yaron Conforti, CEO and Director of Novamind. “Our clinics and clinical research sites are growing rapidly, and we are pleased to be recognized as a leading company in the emerging psychedelics sector.”
Additional information on the ETF can be found here.
Novamind to be featured in panel discussion on the disruptive potential of psychedelic medicine in mental healthcare
We will participate in the Benzinga Healthcare Small Cap Conference taking place virtually on September 29-30, 2021.
Novamind’s CEO and Director, Yaron Conforti, will join a panel of industry leaders for a discussion titled, “Addressing Mental Health through Emerging Therapies” on Thursday, September 30 at 12:35 PM EST.
Following the panel, from 1:15 PM to 1:30 PM EST, Mr. Conforti will deliver a presentation to update investors on the Company’s rapidly growing network of psychiatry clinics and clinical research sites focused on psychedelic medicine. A short Q&A session will follow.
We are pleased to announce that our common shares are now eligible for electronic clearing and settlement through the Depository Trust Company (“DTC”) in the U.S.
The DTC is a subsidiary of the Depository Trust & Clearing Corporation, a U.S. company that manages the electronic clearing and settlement of publicly traded companies. Securities that are eligible to be electronically cleared and settled through DTC are considered ‘DTC eligible’. This electronic method of clearing securities speeds up the receipt of stock and cash and accelerates the settlement process for investors and brokers.
“We are pleased to have become DTC eligible. Investors will benefit from the accelerated settlement process and ability to trade Novamind shares through a wide range of U.S. brokerage firms,” said Yaron Conforti, Chief Executive Officer and Director of Novamind. “This is an important step towards increased liquidity for our stock and building a strong presence for Novamind in the U.S. capital markets.”
A recap of some of the most promising psychedelic drugs for mental health and some of the trailblazers paving the way for the psychedelic revolution. “Sleep, exercise, therapy and antidepressants are some of the top remedies prescribed to assist the 1 in 4 Americans who struggle with mental health issues. But while these are all critical and effective tools, are they enough?”
Novamind’s business model was structured to be drug agnostic. We want to be able to provide the best possible therapies for our clients, regardless of what therapies they end up needing. It’s why we’re a champion for increasing access to all psychedelics. In this article, Shayla Love covers how those interested in psychedelics are learning to work together for the greater good.
Posted by AGORACOM-JC
at 4:35 PM on Friday, September 24th, 2021
FOBI is a global leader in providing real-time data analytics through artificial intelligence to drive customer activation and engagement in the brick and mortar space. From that core technology they have built a technology stack on top of it that is second to none.
They have created multiple successful applications that, for the purposes of this interview, includes their venue management platform that has been deployed at multiple NCAA tournaments, a recent MGM Resorts Championship PGA Event in Las Vega and most recently signed a deal to bring their venue management solutions to the Canadian Hockey League, the world’s largest development hockey league With 9 Million Fan Visits in 2019.
In this interview we discuss not 1 but 3 great press releases:
Sit back and watch this powerful interview with CEO Rob Anson.
Tags: AI, Amazon, artificial intelligence, Big data, Bitcoin, covid19 Posted in Fobi AI | Comments Off on VIDEO – Fobi Is A Global Leader in Providing Real-Time Data Analytics Through Artificial Intelligence to Drive Customer Activation and Engagement
Posted by AGORACOM-JC
at 5:22 PM on Thursday, September 23rd, 2021
Valeo Pharma is already a successful, revenue generating, small cap Canadian pharmaceutical company that acquires the Canadian rights to commercialized drugs in other parts of the world that don’t have Canada on their radar as a target market.
This “in-license” business model is ingenious because it means ZERO developmental or clinical risk, which is the downfall of most small cap pharma companies.
The company recently released Q3 results and highlights:
· Record revenues of $5.7 million for Q3 2021, up 280% over Q3 2020 and 114% over prior quarter.
· Record gross margin of $2.2 million , up 1602% over Q3 2020 and 204% over prior quarter.
· Record 9 months revenues at $10.2 million , up 94%.
· Private and public reimbursement coverage expanding for Redesca®
· New corporate structure completed with full commercial activities ongoing for Redesca®, Enerzair® Breezhaler® and Atectura® Breezhaler®
As you can see above, Valeo is hitting on all cylinders with tremendous revenue growth from new great drugs hitting the Canadian markets as we speak. As a result, the company estimates annual revenue of $160M by 2025.
Now sit back, relax and watch this powerful interview with Steve Saviuk CEO of Valeo Pharma.
Posted by AGORACOM-JC
at 4:06 PM on Thursday, September 23rd, 2021
“I called BS when I first heard about Draganfly’s ability to use my phone’s camera to check all of my vital signs … but when I saw it I was blown away” ($FOBI CEO Rob Anson)
“Fobi has built the best venue management systems for conferences & events in the world. We’re honoured to be integrated with them” $DPRO CEO Cameron Chell
If you’re a shareholder of one of these companies, here is what you need to know about each that makes this technology partnership so powerful:
DRAGANFLY is the creator of cutting-edge drone solutions, software and AI systems that revolutionize the way organizations can do business. Recognized as being at the forefront of drone technology for over 22 years, Draganfly is an award-winning, industry-leader with TIER-1 clients serving industries such as law enforcement, public safety, agriculture, industrial inspections, mapping, and surveying markets.
They have created multiple successful applications that, for the purposes of this interview, includes their Vital Intelligence products that have been game-changers for universities, corrections facilities, sporting events and large scale conferences over the course of the past 18 months. Why? Their software can measure visitors’ vital signs like temperature, cough, and respiratory rate through the camera on your phone or on their drones.
FOBI is a global leader in providing real-time data analytics through artificial intelligence to drive customer activation and engagement in the brick and mortar space. From that core technology they have built a technology stack on top of it that is second to none.
They have created multiple successful applications that, for the purposes of this interview, includes their venue management platform that has been deployed at multiple NCAA tournaments, a recent MGM Resorts Championship PGA Event in Las Vega and most recently signed a deal to bring their venue management solutions to the Canadian Hockey League, the world’s largest development hockey league With 9 Million Fan Visits in 2019
Posted by AGORACOM-JC
at 9:35 AM on Thursday, September 23rd, 2021
The Virtual Reality / Augmented Reality (VRAR) market is projected to hit $1.5 TRILLION (not a typo) by 2030. The applications will be enormous from military to e-commerce to … GAMING and that’s where Fantasy 360 Technologies $VRAR comes in.
F360 is building entire virtual reality worlds inside shipping containers that become unbelievable immersive theme parks. The company refers to it as a “theme park in a container” because of its modular and mobile container based system.
SEEING IS BELIEVING
If you can’t imagine it, we don’t blame you, that’s why we’ve included a 60 second demo clip inside this interview … or you can watch it right now … to be blown away by the experience.
The container model enables entertainment center operators (those 50,000 – 100,000 square foot facilities full of games and restaurants) to offer immersive virtual reality entertainment experiences anywhere in the world.
More than just lip service, CEO Tim Bieber says they have received “overwhelming response” and expect significant orders in the very near future. And you can take that to the bank because $VRAR already has a track record of success in its first 4 years as a private company:
$5.5 Million In Revenues
Deployed 60+ Interactive Experiences Around The World
Clients Include – Intel, Capital One, Scotia Bank, Snickers and even the US Food & Drug Admininstration
If you haven’t heard of $VRAR before it’s probably because they just listed on the CSE in the first week of September, so this is your chance to discover a small cap virtual reality augmented reality almost from the get go.
Watch this amazing interview with CEO Tim Bieber … and make sure to watch the 60 second demo clip either inside the interview or with the link provided above.
Posted by AGORACOM-JC
at 4:36 PM on Wednesday, September 22nd, 2021
Most of us know drones for their recreational uses or perhaps even as simple commercial applications for things like real estate videos.
But the fact of the matter is that drone usage is about to go parabolic with huge corporations adopting them for a wide-use of applications that most never dreamed of such as:
To provide Internet connections in remote locations.
To collect crowd data.
And now package delivery
According to the Drone Package Delivery Global Market Report 2021, the global drone package delivery market is expected to grow to nearly US$1 billion in 2021 at a compound annual growth rate (“CAGR”) of 45.5%. In 2025, the market is expected to reach US$4.4 billion at a CAGR of 45.1%.
In short, the drone industry is booming in ways people can’t imagine because the industry is shifting from the drones themselves (hardware) to drone technology and solutions (software)… and the one company that is delivering the most challenging applications is Draganfly Inc. (DPRO: NASDAQ) (DPRO: CSE)
DraganFly is an award-winning drone manufacturer and technology developer that is actually delivering some pretty incredible achievements, milestones and even history:
Established in 1998 DFLY is considered the oldest commercial drone company in the world
Built the first drone that saved a life
Boasts the first drone to be inducted into the Smithsonian National Air & Space Museum
Developing a Vaccine Drone Delivery Payload System (it’s way more complicated than just transporting vaccines)
Detect infectious conditions in a person from a distance of 190 feet
Conduct phenotyping, data collection and analysis by the USDA
· Vital Intelligence Smart Vital System Now Available in Fobi’s Venue Management System for Conferences & Events
With all of this under the Company’s belt, it’s easy to see why the company recently uplisted to the NASDAQ.
If you believe in the massive parabolic growth in the use of drones for almost everything we do in this world, or want to learn, then watch / listen to this powerful interview with Draganfly CEO and Chairman, Cameron Chell.
